Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Some common medications can harm male fertility, but many effects can be reversed.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Finasteride can treat prostatic haematuria, but its use is controversial.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

Menopause can cause skin issues, and seeing a dermatologist helps.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

The skin microbiome helps heal wounds and can be targeted to improve healing.